Department of Health and Human Services
Key Dates
Release/Posted Date: April 24, 2008
Opening Date: September 17, 2008 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date(s): September 17, 2008
NOTE: On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization).
Application Due Date(s): October 17, 2008
Peer Review Date(s): January/February 2009
Council Review Date(s): May 2009
Earliest Anticipated Start Date(s): July 2009
Purpose. The National Institute on Drug Abuse on behalf of the NIH Genes, Environment and Health Initiative encourages functional characterization of genetic variants that have been statistically nominated to be associated with a particular outcome through common, complex disease gene discovery approaches, such as genome-wide association studies, candidate gene approaches, or sequencing studies. This FOA supports research relating genetic variation to biological mechanism, or disease causality. Areas of interest include, but are not limited to, relatively low throughput approaches (e.g. transgenic mouse approaches) to test some of the most promising variants for changes in function; or exploit high-throughput tests (e.g. yeast, C. elegans, cell culture systems, or computational approaches) to look at different aspects of variant function.